Moderna (MRNA) shares plunge over 17% after leak of cancer vaccine data
FROM THE WIRE · GURUFOCUS.COM
On October 25, 2026, Moderna Inc (NASDAQ: MRNA) saw its stock price drop sharply by more than 17% following the premature release of preliminary data on its per
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe stock of a mid-sized biotech reacted sharply to the premature release of preliminary data.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01On October 25, 2026, Moderna shares fell more than 17%.
- 02The drop followed the premature release of preliminary data on a cancer vaccine.
- 03The stock trades on NASDAQ under the ticker MRNA.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets